ArticleHaematologica2026

Infection risk in 158 patients with relapsed/refractory multiple myeloma treated with bispecific antibodies: a single-center experience.

Lorenzo Cani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.